Page last updated: 2024-11-06

thymidine and Hyperparathyroidism, Secondary

thymidine has been researched along with Hyperparathyroidism, Secondary in 2 studies

Hyperparathyroidism, Secondary: Abnormally elevated PARATHYROID HORMONE secretion as a response to HYPOCALCEMIA. It is caused by chronic KIDNEY FAILURE or other abnormalities in the controls of bone and mineral metabolism, leading to various BONE DISEASES, such as RENAL OSTEODYSTROPHY.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nakajima, K1
Umino, K1
Azuma, Y1
Kosaka, S1
Takano, K1
Obara, T1
Sato, K1
Alexiewicz, JM1
Klinger, M1
Pitts, TO1
Gaciong, Z1
Linker-Israeli, M1
Massry, SG1

Other Studies

2 other studies available for thymidine and Hyperparathyroidism, Secondary

ArticleYear
Stimulating parathyroid cell proliferation and PTH release with phosphate in organ cultures obtained from patients with primary and secondary hyperparathyroidism for a prolonged period.
    Journal of bone and mineral metabolism, 2009, Volume: 27, Issue:2

    Topics: Calcium; Cell Proliferation; Gene Expression Regulation; Humans; Hyperparathyroidism, Primary; Hyper

2009
Parathyroid hormone inhibits B cell proliferation: implications in chronic renal failure.
    Journal of the American Society of Nephrology : JASN, 1990, Volume: 1, Issue:3

    Topics: Adult; Aged; B-Lymphocytes; Cell Division; Colforsin; Cyclic AMP; Female; Humans; Hyperparathyroidis

1990